Login / Signup

Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients.

Rei SakataShiro MizoueKeiji YoshikawaMisato AdachiShinji OhkuboNaoki HamadaTomoko NaitoTomoyuki MuramatsuTakeshi HaraRyo AsatoMakoto Aihara
Published in: Japanese journal of ophthalmology (2023)
BBFC can be used concomitantly with PG or PG/beta FC to reduce IOP without serious complications.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • risk factors
  • patient reported outcomes
  • optical coherence tomography